Sotigalimab Uses, Dosage, Side Effects and more
Sotigalimab is under investigation in clinical trial NCT03123783 (CD40 Agonistic Antibody APX005M in Combination With Nivolumab).
| Trade Name | Sotigalimab |
| Generic | Sotigalimab |
| Sotigalimab Other Names | Sotigalimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
